Exclusive deal covers U.S. and Canada.

International Stem Cell (ISCO) inked an exclusive deal with CellSystems Biotechnologie to distribute laboratory-cultured models of human skin within the U.S. and Canada. The product can be used for testing consumer products and for dermatological and pharmaceutical research, according to the companies.

The laboratory-cultured models of human skin, called EST-1000 and AST-2000, were developed by CellSystems and contain cells manufactured by Lifeline Cell Technology, ISCO’s wholly owned subsidiary.

“While the sale of these Lifeline stem cell and research products provides ISCO immediate cash flow,” notes ISCO president, Jeffrey Janus, “it also helps embed ISCO’s products into successful therapeutic and quality control procedures worldwide, providing a revenue stream of shared royalties beyond traditional sales.”

Previous articleGlobal Consortium Formed to Conduct Genomic Analysis of 50 Cancers
Next articleScientists Identify Protein Target to Block HIV’s Entrance into T Cells